Inventor · disambiguated record
Timothy John Norman
Also filed as: NORMAN TIMOTHY JOHN
22 granted patents·7 pending applications·93 citations·filing 1999–2024
94Inventor score
Files withUCB Biopharma SRL14CELLTECH R&D LTD6UCB PHARMA SA4UCB BIOPHARMA SPRL3BAKER TERENCE SEWARD1
Top patents by PatentIndex Score
29 records- 0196US10705094B2TNF receptor signaling modulator assayUCB Biopharma SRL·Filed 2015·Granted Jul 7, 2020·9 cites·18 claims
- 0295US10883996B2Methods of identifying signaling modulators of the trimeric TNFaUCB Biopharma SRL·Filed 2015·Granted Jan 5, 2021·7 cites·5 claims
- 0393US11448655B2Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptorsUCB Biopharma SRL·Filed 2020·Granted Sep 20, 2022·2 cites·17 claims
- 0493US10775385B2Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimersUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·7 cites·4 claims
- 0592US11674967B2Method of identifying potential inhibitors of APO TNFα trimersUCB Biopharma SRL·Filed 2020·Granted Jun 13, 2023·2 cites·19 claims
- 0689US2025012807A1Mechanism of actionUCB Biopharma SRL·Filed 2024·Application pending·0 cites
- 0785US12474348B2Complexes between CD40 and compounds comprising benzimidazole moietiesUCB Biopharma SRL·Filed 2022·Granted Nov 18, 2025·0 cites·6 claims
- 0884US7531676B2LipidsCELLTECH R&D LTD·Filed 2005·Granted May 12, 2009·7 cites·19 claims
- 0983US7910618B2Albumin-binding conjugates comprising a fatty acid and PEGUCB PHARMA SA·Filed 2005·Granted Mar 22, 2011·2 cites·15 claims
- 1080US6610700B2Enamine derivativesCELLTECH R&D LTD·Filed 2001·Granted Aug 26, 2003·13 cites·11 claims
- 1177US9550737B2TNF -α modulating benzimidazolesUCB BIOPHARMA SPRL·Filed 2013·Granted Jan 24, 2017·4 cites·10 claims
- 1277US2021140972A1Mechanism of actionUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 1376US6780874B2Enamine derivativesCELLTECH R&D LTD·Filed 2003·Granted Aug 24, 2004·8 cites·20 claims
- 1471US8053564B2Cross-linked antibodiesUCB PHARMA SA·Filed 2005·Granted Nov 8, 2011·1 cites·4 claims
- 1571US7736635B2Branched molecular scaffolds for linking polymer residues to biologically active moietiesUCB PHARMA SA·Filed 2004·Granted Jun 15, 2010·3 cites·6 claims
- 1670US8129505B2Comb polymersNORMAN TIMOTHY JOHN·Filed 2006·Granted Mar 6, 2012·6 cites·10 claims
- 1767US12018021B2Thiophene derivatives for the treatment of disorders caused by IgEUCB Biopharma SRL·Filed 2019·Granted Jun 25, 2024·1 cites·15 claims
- 1865US10287299B2Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activityUCB BIOPHARMA SPRL·Filed 2016·Granted May 14, 2019·1 cites·6 claims
- 1965US7557130B2Bicyclic heteroaromatic alaninesUCB PHARMA SA·Filed 2002·Granted Jul 7, 2009·3 cites·13 claims
- 2059US6583301B1LipidsCELLTECH R&D LTD·Filed 1999·Granted Jun 24, 2003·17 cites·43 claims
- 2159US2004024220A1LipidsCELLTECH R&D LTD·Filed 2003·Application pending·0 cites
- 2252US2024140951A1Imidazopyridazine derivatives as il-17 modulatorsUCB Biopharma SRL·Filed 2021·Application pending·0 cites
- 2349US12410161B2Tetrahydrobenzo-quinoline sulfonamides derivative compoundsUCB Biopharma SRL·Filed 2020·Granted Sep 9, 2025·0 cites·18 claims
- 2448US2023192646A1Dihydro-cyclopenta-isoquinoline derivativesUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2546US2024092773A1Dihydro-cyclopenta-isoquinoline sulfonamides derivativesUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2645US10842884B2Endosomolytic agents for gene therapyUCB Biopharma SRL·Filed 2017·Granted Nov 24, 2020·0 cites·21 claims
- 2743US2023050670A1Tetrahydrobenzo-quinoline sulfonamide derivatives useful as ige modulatorsUCB Biopharma SRL·Filed 2020·Application pending·0 cites
- 2841US6603041B2Bicyclic enamide derivativesCELLTECH R&D LTD·Filed 2001·Granted Aug 5, 2003·0 cites·23 claims
- 2934US7718157B1Targeted lipid particlesBAKER TERENCE SEWARD·Filed 2000·Granted May 18, 2010·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Timothy John Norman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →